ETFdb Logo
ETFdb Logo
  • ETF Database
  • Channels
    • Themes
      • Active ETF
      • Artificial Intelligence
      • Beyond Basic Beta
      • China Insights
      • Climate Insights
      • Core Strategies
      • Crypto
      • Direct Indexing
      • Disruptive Technology
      • Energy Infrastructure
      • ETF Building Blocks
      • ETF Investing
      • ETF Education
      • ETF Strategist
      • Financial Literacy
      • Fixed Income
      • Free Cash Flow
      • Innovative ETFs
      • Institutional Income Strategies
      • Leveraged & Inverse
      • Managed Futures
      • Market Insights
      • Modern Alpha
      • Multifactor
      • Responsible Investing
      • Retirement Income
      • Tax Efficient Income
    • Asset Class
      • Equity
        • U.S. Equity
        • Int'l Developed
        • Emerging Market Equities
      • Alternatives
        • Commodities
        • Gold/Silver/Critical Minerals
        • Currency
        • Volatility
      • Fixed Income
        • Investment Grade Corporates
        • US Treasuries & TIPS
        • High Yield Corporates
        • Int'l Fixed Income
    • ETF Ecosystem
    • ETFs in Canada
  • Tools
    • ETF Screener
    • ETF Country Exposure Tool
    • ETF Sector Tracker Tool
    • ETF Database Categories
    • Head-To-Head ETF Comparison Tool
    • ETF Stock Exposure Tool
    • ETF Issuer Fund Flows
    • Indexes
    • Mutual Fund To ETF Converter
  • Research
    • ETF Education
    • Equity Investing
    • Dividend ETFs
    • Leveraged ETFs
    • Inverse ETFs
    • Index Education
    • Index Insights
    • Top ETF Sectors
    • Top ETF Issuers
    • Top ETF Industries
  • Webcasts
  • Themes
    • AI ETFs
    • Blockchain ETFs
    • See all Thematic Investing ETF themes
    • ESG Investing
    • Marijuana ETFs
  • Multimedia
    • ETF 360 Video Series
    • ETF of the Week Podcast
    • ETF Prime Podcast
    • Video
  • Company
    • About VettaFi
    • Get VettaFi’ed
  • PRO
    • Pro Content
    • Pro Tools
    • Advanced
    • FAQ
    • Pricing
    • Free Sign Up
    • Login
  1. Two ETF Newcomers Log in Impressive Gains (SBIO, BBC)
News
Share

Two ETF Newcomers Log in Impressive Gains (SBIO, BBC)

Daniela Pylypczak-WasylyszynMar 16, 2015
2015-03-16

With the S&P 500 and Dow Jones Industrial Average struggling to stay in the green, and the Nasdaq logging in only minor returns, equity markets have been somewhat underwhelming thus far in 2014. There are, however, a handful of ETFs that have managed to log in double digit returns, two of which made their debut on Wall Street just a few months ago.

SBIO and BBC Post Stellar Gains

The Medical Breakthroughs ETF (SBIO B-) and the BioShares Biotechnology Clinical Trials Fund (BBC C) are two of the newest funds on the market, launching in December of 2014. Already, these funds have gained investors’ attention. SBIO has managed to rake in over $37 million in assets, while BBC has just over $13.5 million.

Since the start of 2015, these two Health & Biotech Equities ETFs have managed to significantly outperform the broader market, as well as the popular QQQ. The chart below highlights the three funds’ year-to-date performance (as of 3/13/2015):


Content continues below advertisement

Chart of SBIO vs BBC vs QQQ

YTD both SBIO and BBC are up roughly 20%, as compared to QQQ’s gain of only about 1.7%. Excluding leveraged and inverse funds, these two ETFs are also among the biggest gainers on the year.

Unique Exposure to the Health Industry

picture of DNA strand

SBIO and BBC were both featured in our list of the Top 10 ETFs to Be Excited About in 2015, due to their unique approach to the health and biotech industry.

ALPS’ SBIO tracks an index that is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III of U.S. Food and Drug Administration clinical trials. This allows investors to tap into some of the most innovative companies in the biotech space.

Another key and beneficial feature of SBIO is that one of its screening methodologies includes selecting only those companies that have enough cash for 24 months at the current burn rate. This strategy helps mitigate the potential downside risk that is commonly found in small companies in this industry.

BioShares’ BBC offers similar exposure to the biotech industry, but also includes companies with a product offering that is in Phase 1 clinical trial stage of development. The fund holds just over 65 individual holdings, the majority of which have market capitalizations between $2 billion and $10 billion.

A compelling feature of BBC is that its portfolio does not allocate more than 4.0% of total assets to a single security, making it relatively more balanced and safer considering the number of young and small companies.

The Bottom Line

While these two funds are new to the scene, investors have already started to notice the unique exposure and stellar performance of both SBIO and BBC. As always, we encourage you to take a close look under the hood of any ETFs you may be considering, making sure the fund fits with your risk/return profile.

Follow me on Twitter @DPylypczak.

Disclosure: No positions at time of writing.

» Popular Pages

  • Tickers
  • Articles

Sep 29

A Fixed Income Primer for Constructing Portfolios

Sep 29

Main Management Market Note: September 29, 2023

Sep 29

Higher for Much Longer?

Sep 29

Moving Averages: S&P Ends September Down 4.9%

Sep 29

This Week in ETFs: FormulaFolios Renamed & Adds New Funds

Sep 29

Play Online Car Sales News in These 2 China ETFs

Sep 29

SEC Opens Ethereum Futures ETF Floodgates

Sep 29

VettaFi Voices On: Managing Risk in an Uncertain Economy

Sep 29

SPYI Outperforms SPY in Challenging 3rd Quarter

Sep 29

More Rate Hikes? Watch Treasury ETF USFR

QQQ

Invesco QQQ Trust Series I

SPY

SPDR S&P 500 ETF Trust

VOO

Vanguard S&P 500 ETF

JEPI

JPMorgan Equity Premium...

TSLY

YieldMax TSLA Option Income...

SMH

VanEck Semiconductor ETF

VTI

Vanguard Total Stock Market...

SCHD

Schwab US Dividend Equity ETF...

QQQM

Invesco NASDAQ 100 ETF

IVV

iShares Core S&P 500 ETF


Content continues below advertisement

Loading Articles...
Our Sites
  • VettaFi
  • Advisor Perspectives
  • ETF Trends
Tools
  • ETF Screener
  • Mutual Fund to ETF Converter
  • Head-To-Head ETF Comparison
  • ETF Country Exposure Tool
  • ETF Stock Exposure Tool
  • ETF Database Pro
More Tools
  • Financial Advisor & RIA Center
Explore ETFs
  • ETF News
  • ETF Category Reports
  • Premium Articles
  • Alphabetical Listing of ETFs
  • Browse ETFs by ETF Database Category
  • Browse ETFs by Index
  • Browse ETFs by Issuer
  • Compare ETFs
Information
  • Contact Us
  • Terms of Use and Privacy Policy
  • © 2023 VettaFi LLC. All rights reserved.

Advertisement

Is Your Portfolio Positioned With Enough Global Exposure?

ETF Education Channel

How to Allocate Commodities in Portfolios

Tom LydonApr 26, 2022
2022-04-26

A long-running debate in asset allocation circles is how much of a portfolio an investor should...

Core Strategies Channel

Why ETFs Experience Limit Up/Down Protections

Karrie GordonMay 13, 2022
2022-05-13

In a digital age where information moves in milliseconds and millions of participants can transact...

}
X